LHRH Analogues in Endometriosis
editorial
OA: closed
CC0
⤵ 3 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This review discusses the use of LHRH analogues for endometriosis treatment, highlighting their efficacy in reducing pain and lesion size by suppressing ovarian function.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (30)
- Clinical Management of Endometriosis with Luteinizing Hormone - Releasing Hormone Analogues via openalex
- Endocrine effects of danazol in the treatment of endometriosis via openalex
- ENDOMETRIOSIS AND OVULATORY DISORDER: REDUCED FERTILISATION IN VITRO COMPARED WITH TUBAL AND UNEXPLAINED INFERTILITY via openalex
- Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis. via openalex
- “MEDICAL OOPHORECTOMY” USING A LONG-ACTING GNRH AGONIST-A POSSIBLE NEW APPROACH TO THE TREATMENT OF ENDOMETRIOSIS. via openalex
- Revised American Fertility Society Classification of Endometriosis: 1985 via openalex
- Suppression of Follicular Maturation by Infusion of a Luteinizing Hormone-Releasing Hormone Agonist Starting during the Late Luteal Phase in the Stumptailed Macaque Monkey via openalex
- W2052668236 via openalex
- W2059441670 via openalex
- W2060787751 via openalex
- W2068758998 via openalex
- W170259557 via openalex
- W2077563872 via openalex
- W2084296217 via openalex
- W2126534105 via openalex
- W2153177934 via openalex
- W2210149071 via openalex
- W2227993884 via openalex
- W2321572808 via openalex
- W2408619637 via openalex
- W2409648342 via openalex
- W2477008945 via openalex
- W4239639419 via openalex
- W2074185602 via openalex
- W1618997004 via openalex
- W1964499150 via openalex
- W1971746318 via openalex
- W2018739526 via openalex
- W2024862737 via openalex
- W2042415727 via openalex
Cited by (3)
- Renal endometriosis treated with a gonadotrophin releasing hormone agonist. Case report 1991
- THE EFFECT OF DANAZOL AND THE LHRH AGONIST ANALOGUE GOSERELIN (ZOLADEX) ON THE BIOLOGICAL ACTIVITY OF LUTEINIZING HORMONE IN WOMEN WITH ENDOMETRIOSIS 1990
- Treatment of Endometriosis by Nasal Administration of Nafarelin 1987
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:09:35.489789+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK